| Dr Robert G Manahan, MD | |
|
535 Fortune Dr, Ste 200, Papillion, NE 68046-3428 | |
| (402) 934-9033 | |
| (402) 934-9506 |
| Full Name | Dr Robert G Manahan |
|---|---|
| Gender | Male |
| Speciality | Ophthalmology |
| Experience | 25 Years |
| Location | 535 Fortune Dr, Papillion, Nebraska |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043264062 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207W00000X | Ophthalmology | 22754 (Nebraska) | Primary |
| Entity Name | Manahan Eye Associates Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1033219373 PECOS PAC ID: 6002831559 Enrollment ID: O20051013000327 |
News Archive
In recent years, hospitals have reported dramatic increases in the number of cases of the highly contagious, difficult-to-treat, and often deadly antibiotic-resistant bacteria carbapenem-resistant Enterobacteriaceae (CRE). Now, investigators at Beth Israel Deaconess Medical Center have developed a promising method of identifying new antimicrobials that target these organisms. The research is published in April issue of the journal ASSAY and Drug Development Technologies.
Population aging could peak by 2040 in Germany and by 2070 in China, according to a new study published in the journal PLOS ONE, which combines new measures of aging with probabilistic population projections from the UN. In the USA, the study shows very little population aging at all in the coming century.
On June 9, 2010, Invivo was recognized with a 2010 Gold Medical Design Excellence Award for its DynaCAD for Prostate and DynaTRIM (Trans-Rectal Interventional MRI) clinical solutions. The MDEA awards ceremony took place in early June at New York City's Jacob K. Javits Convention Center where gold and silver winners were honored.
Results of an advanced clinical trial of an antiretroviral-based microbicide candidate are being announced at the International AIDS Conference in Vienna, Austria. The CAPRISA 004 trial, which tested the safety and effectiveness of 1% tenofovir gel among nearly 900 women at two sites in South Africa, found that using the gel before and after sex provided moderate protection against sexually transmitted HIV.
› Verified 8 days ago
| Entity Name | Robert Manahan Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1346754660 PECOS PAC ID: 7315201746 Enrollment ID: O20180510000913 |
News Archive
In recent years, hospitals have reported dramatic increases in the number of cases of the highly contagious, difficult-to-treat, and often deadly antibiotic-resistant bacteria carbapenem-resistant Enterobacteriaceae (CRE). Now, investigators at Beth Israel Deaconess Medical Center have developed a promising method of identifying new antimicrobials that target these organisms. The research is published in April issue of the journal ASSAY and Drug Development Technologies.
Population aging could peak by 2040 in Germany and by 2070 in China, according to a new study published in the journal PLOS ONE, which combines new measures of aging with probabilistic population projections from the UN. In the USA, the study shows very little population aging at all in the coming century.
On June 9, 2010, Invivo was recognized with a 2010 Gold Medical Design Excellence Award for its DynaCAD for Prostate and DynaTRIM (Trans-Rectal Interventional MRI) clinical solutions. The MDEA awards ceremony took place in early June at New York City's Jacob K. Javits Convention Center where gold and silver winners were honored.
Results of an advanced clinical trial of an antiretroviral-based microbicide candidate are being announced at the International AIDS Conference in Vienna, Austria. The CAPRISA 004 trial, which tested the safety and effectiveness of 1% tenofovir gel among nearly 900 women at two sites in South Africa, found that using the gel before and after sex provided moderate protection against sexually transmitted HIV.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Robert G Manahan, MD 535 Fortune Dr, Ste 200, Papillion, NE 68046-3428 Ph: (402) 934-9033 | Dr Robert G Manahan, MD 535 Fortune Dr, Ste 200, Papillion, NE 68046-3428 Ph: (402) 934-9033 |
News Archive
In recent years, hospitals have reported dramatic increases in the number of cases of the highly contagious, difficult-to-treat, and often deadly antibiotic-resistant bacteria carbapenem-resistant Enterobacteriaceae (CRE). Now, investigators at Beth Israel Deaconess Medical Center have developed a promising method of identifying new antimicrobials that target these organisms. The research is published in April issue of the journal ASSAY and Drug Development Technologies.
Population aging could peak by 2040 in Germany and by 2070 in China, according to a new study published in the journal PLOS ONE, which combines new measures of aging with probabilistic population projections from the UN. In the USA, the study shows very little population aging at all in the coming century.
On June 9, 2010, Invivo was recognized with a 2010 Gold Medical Design Excellence Award for its DynaCAD for Prostate and DynaTRIM (Trans-Rectal Interventional MRI) clinical solutions. The MDEA awards ceremony took place in early June at New York City's Jacob K. Javits Convention Center where gold and silver winners were honored.
Results of an advanced clinical trial of an antiretroviral-based microbicide candidate are being announced at the International AIDS Conference in Vienna, Austria. The CAPRISA 004 trial, which tested the safety and effectiveness of 1% tenofovir gel among nearly 900 women at two sites in South Africa, found that using the gel before and after sex provided moderate protection against sexually transmitted HIV.
› Verified 8 days ago
Celia R Manahan, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 535 Fortune Dr, Ste 200, Papillion, NE 68046 Phone: 402-934-9033 Fax: 402-934-9506 | |
Gerald S Ferenstein, MD Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 401 East Gold Coast Rd, Suite 203, Papillion, NE 68046 Phone: 402-592-4750 Fax: 402-592-4750 |